根治性膀胱切除术延迟对膀胱癌患者生存影响的系统综述与荟萃分析
结果显示从膀胱癌诊断到根治性膀胱切除术的较长延迟与总死亡风险显著增加相关,合并风险比为1.34(95%CI:1.18-1.53);而经尿道电切至膀胱切除术的延迟及新辅助化疗至膀胱切除术的延迟,合并风险比分别为1.18(95%CI:0.99-1.41)和1.04(95%CI:0.93-1.16)。
要点
- 诊断至根治性膀胱切除术延迟显著降低总生存,合并HR 1.34(95%CI:1.18-1.53)。
- 经尿道电切至膀胱切除术延迟的合并HR为1.18(95%CI:0.99-1.41)。
- 新辅助化疗至膀胱切除术延迟的合并HR为1.04(95%CI:0.93-1.16)。
核心结论
- 诊断后延迟根治性膀胱切除术对膀胱癌患者总生存有显著不利影响。
- 延迟的定义在各研究间存在巨大异质性。
研究设计与样本
- 系统综述与荟萃分析,检索Medline和Ovid Gateway,检索时间为2019年8月,无时间限制。
- 使用STROBE清单和ROBINS-I工具评估研究质量与偏倚风险。
- 采用随机效应模型,以延迟存在为暴露变量、总生存为结局,计算合并风险比。
主要发现
- 膀胱癌诊断至根治性膀胱切除术较长延迟的总死亡合并风险比为1.34(95%CI:1.18-1.53)。
- 经尿道电切至膀胱切除术延迟的总死亡合并风险比为1.18(95%CI:0.99-1.41)。
- 新辅助化疗至根治性膀胱切除术延迟的总死亡合并风险比为1.04(95%CI:0.93-1.16)。
临床怎么用
- 应按时安排根治性膀胱切除术,避免诊断后不必要的延迟。
- 安排手术时需同时监测合并症和排期等因素,以及时治疗需要根治性膀胱切除术的患者。
局限性
- 延迟的定义在各研究间存在巨大异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The complexity of bladder cancer diagnosis and staging results in delays in definitive treatment of muscle-invasive bladder cancer by radical cystectomy. OBJECTIVE: This systematic review and meta-analyses aim to assess the impact of delays in radical cystectomy. EVIDENCE ACQUISITION: A systematic review was conducted by searching Medline and Ovid Gateway using protocol-driven search terms in August 2019, with no time limit on the studies included. The identified studies were assessed according to strict criteria and using the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist and Risk of Bias in Non-randomised Studies-of Interventions (ROBINS-I) tool. Meta-analyses were conducted based on the type of delay. Random-effect models were used whereby the presence of a delay was the exposure variable and overall survival was the outcome of interest, for which pooled hazard ratios were calculated. EVIDENCE SYNTHESIS: Nineteen studies were eligible for inclusion (17 532 patients), of which 10 were included in the meta-analyses. A longer delay between bladder cancer diagnosis and radical cystectomy resulted in a pooled hazard ratio of 1.34 (95% confidence interval [CI]: 1.18-1.53) for overall death. For a delay between transurethral resection and cystectomy, we found a pooled hazard ratio of 1.18 (95% CI: 0.99-1.41) for overall death. A pooled hazard ratio of 1.04 (95% CI: 0.93-1.16) was calculated for a longer delay between neoadjuvant chemotherapy and radical cystectomy. CONCLUSIONS: A delay in radical cystectomy after diagnosis was found to have a significantly detrimental effect on overall survival for bladder cancer patients. However, there was huge heterogeneity in how a delay was defined. PATIENT SUMMARY: In this review, we investigated the effect of a delay in radical treatment on survival. This review highlights the importance of scheduling radical cystectomies in a timely manner whilst monitoring factors such as comorbidities and scheduling, in order to treat patients requiring radical cystectomy without delay.
引用
- Russell B, Liedberg F, Khan MS, et al. A Systematic Review and Meta-analysis of Delay in Radical Cystectomy and the Effect on Survival in Bladder Cancer Patients. Eur Urol Oncol. 2019. PMID: 31668714. doi:10.1016/j.euo.2019.09.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。